相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Changes in Prevalence of Health Care-Associated Infections in US Hospitals
S. S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients
Lindsey E. Splinter et al.
ANNALS OF PHARMACOTHERAPY (2018)
Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027
N. Kenters et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2017)
Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections
Alex Carignan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents
Nicholas W. Van Hise et al.
CLINICAL INFECTIOUS DISEASES (2016)
Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
Abhishek Deshpande et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review
Erica S. Shenoy et al.
BMC INFECTIOUS DISEASES (2014)
Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non-C difficile Infection
Sandra Rodriguez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
Isaac See et al.
CLINICAL INFECTIOUS DISEASES (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
Zain Kassam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
David W. Eyre et al.
CLINICAL INFECTIOUS DISEASES (2012)
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Oliver A. Comely et al.
CLINICAL INFECTIOUS DISEASES (2012)
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease
Wafa N. Al-Nassir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
分享论文
